Why is Saroja Pharma In falling/rising?

As of 19-Sep, Saroja Pharma Industries India Ltd is experiencing a decline in its stock price, currently at 45.15, reflecting a decrease of 2.3 or 4.85%. The stock has underperformed its sector by 5.12% today, and while it is trading higher than the 50-day and 100-day moving averages, it is below the 5-day, 20-day, and 200-day moving averages. Over the past week, the stock has decreased by 4.04%, and it has seen a significant drop of 19.59% over the past month. Despite a rise in investor participation, with delivery volume increasing by 11.11% against the 5-day average, the overall performance remains negative, with no positive or negative dashboard data available to provide further insights.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark Sensex, which has gained 0.85% over the past week and 1.39% over the past month. Year-to-date, Saroja Pharma's stock has declined by 24.75%, while the Sensex has increased by 7.11%. This significant underperformance indicates that the stock is not only struggling in the short term but also lagging behind the market overall, contributing to investor concerns and the current downward price movement.